Abstract
The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Current Genomics
Title: Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway
Volume: 6 Issue: 6
Author(s): S. H. Slofstra and H. T. Cate
Affiliation:
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Abstract: The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Export Options
About this article
Cite this article as:
Slofstra H. S. and Cate T. H., Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482963
DOI https://dx.doi.org/10.2174/138920205774482963 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Lipid-Lowering Agents on Inflammation, Haemostasis and Blood Pressure
Current Pharmaceutical Design Novel Oral Anticoagulants: Recommendations for Patient Evaluation, Treatment Initiation, Follow-up and Perioperative Management
Cardiovascular & Hematological Disorders-Drug Targets Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Thrombospondin-1 in Von Willebrand Factor Function
Current Drug Targets Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions
Current Chemical Biology Thrombophilia and Pregnancy
Current Pharmaceutical Design Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design Nanotechnology: A Promising Tool Towards Wound Healing
Current Pharmaceutical Design Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine
Current Pharmaceutical Design Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Current Cardiology Reviews Challenges and Promises of Developing Thrombin Receptor Antagonists
Recent Patents on Cardiovascular Drug Discovery Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recent Patents in Cell-Based Strategies for Soft Tissue Engineering in Plastic and Reconstructive Surgery
Recent Patents on Biomedical Engineering (Discontinued) Anabolic Androgenic Steroids Abuse and Liver Toxicity
Mini-Reviews in Medicinal Chemistry tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies Editorial (Hot Topic: The First Theme Issue on PPARs for Brain Disorders)
Current Drug Targets Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Definitions of Metabolic Syndrome: Where are We Now?
Current Vascular Pharmacology